What Transformation Has the Biopreservation Market Market Undergone?
The biopreservation market market has seen considerable growth due to a variety of factors.
•In recent times, the biopreservation market has seen rapid expansion. The market is projected to increase from $6.02 billion in 2024 to $6.7 billion in 2025, showing a Compound Annual Growth Rate (CAGR) of 11.3%.
This growth in the past timeframe can be credited to the expansion of biobanking, increased stem cell research, a rise in organ transplant procedures, biopharmaceutical production, and advancements in cell therapy.
How Will The Biopreservation Market Market Size Evolve In The Foreseeable Future?
The biopreservation market market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of the biopreservation sector is predicted to witness a notable surge in the coming years, potentially reaching a value of $11.09 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 13.4%.
Factors contributing to this anticipated growth during the forecasted period include the escalating demand for regenerative medicine, personalized medicine R&D, cryopreservation applications, the global biopharmaceutical supply chain, and burgeoning initiatives in biobanking. Key trends projected to appear during this period comprise an increased involvement in stem cell banking, an emphasis on innovative preservation solutions, growth in drug discovery and development, the launch of transportable biopreservation machinery, and a rising importance placed on organ transplantation.
What Are The Essential Drivers Behind The Growth Of The Biopreservation Market Market?
The biopreservation market is experiencing significant growth due to the rising demand for personalized medicine. This type of treatment targets diseases that are unique to each patient, and the development of these medicines relies heavily on biobanks. Biobanks use biopreservation methods to maintain human tissues and cells. The Personalized Medicine Coalition, a non-profit organization based in the US, reported in February 2024 that the FDA had approved 16 new personalized therapies for patients with rare diseases in 2023. This was a significant increase from the six approved in 2022. Hence, the upward trend in demand for personalized medicine is anticipated to continue driving the growth of the biopreservation market.
How Is The Global Biopreservation Market Market Divided Into Key Segments?
The biopreservation market market covered in this report is segmented –
1) By Type: Biopreservation Equipment, Biopreservation Media
2) By Biospecimen: Human Tissue Samples, Organs, Stem Cells, Other Biospecimens
3) By Application: Therapeutic Applications, Research Applications, Clinical Trials, Other Applications
4) By End User: Biobanks, Gene Banks, Hospitals, Other End Users
Subsegments:
1) By Biopreservation Equipment: Freezers, Liquid Nitrogen Tanks, Refrigerators, Incubators
2) By Biopreservation Media: Cryoprotectants, Growth Media, Supplementary Media
Pre-Book The Biopreservation Market Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Biopreservation Market Market?
Emerging technology is a prominent trend within the biopreservation sector. Leading companies are moving towards the utilization of advanced technologies like cryopreservation techniques for maintaining the integrity of intricate tissues and organs over long periods. Cryopreservation involves safeguarding materials at extremely cold environments (196 °C), rapidly for purposes such as seed storage, or gradually with continuous dehydration for tissue cultures. For example, Pluristyx, Inc., a biotech company from the US, brought the PluriFreeze Cryopreservation Media to the market in April 2024. This exclusive solution aims to promote the longevity and efficiency of pluripotent stem cells derived from humans (iPSCs), as well as other sensitive cell types, during the freezing and defrosting phases. Available firstly in a formula specifically for research use (RUO), it is anticipated that a version compliant with good manufacturing practice (GMP) will be introduced soon. PluriFreeze is constructed entirely from synthetic and animal-origin free (AOF) components, promoting a safer and more ethical method of cell preservation. The solution's low viscosity permits the automation and production of cells at large scales, while the corresponding DMSO-free cleansing solution, PluriPrep, accommodates longer processing periods, improving cell management and recovery in both research and medical settings.
Who Are the Key Players in the Biopreservation Market Market?
Major companies operating in the biopreservation market market include:
• Thermo Fisher Scientific Inc.
• BioLife Solutions Inc.
• VWR International LLC
• BioCision LLC
• Lifeline Scientific Inc.
• Biomatrica Inc.
• Custom Biogenic System Inc.
• QIAGEN NV
• ThermoGenesis Holdings Inc.
• MVE Biological Solutions LLC
• Taylor-Wharton America Inc.
• X-Therma Inc.
• Cesca Therapeutics Inc.
• Core Dynamics Ltd.
• The Merck Group
• Azenta US Inc.
• Avantor Inc.
• Bio-Techne Corporation
• Worthington Industries Inc.
• Chart Industries Inc.
• Cryoport Inc.
• LabVantage Solutions Inc.
• Brooks Automation Inc.
• BioVault Technical Ltd.
• Biomatik Corporation
• Biostorage Technologies Inc.
• Arctiko A/S
• Eppendorf AG
• Panasonic Healthcare Co. Ltd.
• BioSpherix Ltd.
What are the Regional Insights into the Biopreservation Market Market?
North America was the largest region in the biopreservation market share in 2024. The regions covered in the biopreservation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
